Clinical Trials Directory

Trials / Completed

CompletedNCT01945970

Effect of Black Tea on Vascular Function

Randomized Double Blind Placebo Controlled Crossover Study to Assess the Effect of Black Tea on Flow-Mediated Dilation in Healthy, Non-tea Drinking Males

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
30 (actual)
Sponsor
Unilever R&D · Industry
Sex
Male
Age
40 Years – 65 Years
Healthy volunteers
Accepted

Summary

Epidemiological studies indicate that regular consumption of three cups of black tea per day reduces the risk of stroke or myocardial infarction. In a number of previous nutrition intervention studies tea has been shown to improve vascular function as assessed by Flow Mediated Dilation (FMD).

Detailed description

The current study tests a specific Black tea extract against a placebo in population that has previously show to be sensitive to the effect of black tea on Flow Mediated dilation. A tea extract that has previously been shown to improve FMD is included as the positive control.

Conditions

Interventions

TypeNameDescription
OTHERBlack tea extractBlack tea extract
OTHERPositive controlPositive control
OTHERPlaceboPlacebo

Timeline

Start date
2013-09-01
Primary completion
2013-11-01
Completion
2013-12-01
First posted
2013-09-19
Last updated
2017-03-22
Results posted
2017-02-17

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT01945970. Inclusion in this directory is not an endorsement.